LIFEMD, INC. (LFMD) Operating Margin
- Operating margin · 12 months: Value -10.54%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -10.54% | Operating income / revenue. Period ending 2026-06-30. $-20.20M ÷ $191.59M × 100 ≈ -10.54% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -20.20M USD | Operating Income (Loss) |
| Revenue | 191.59M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | |
| Research and development | (m) | Research and Development Expense |
| Selling, general and administration | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-20.20M | $191.59M | (m) | (m) | (m) | -10.54% |
| 2026-03-31 | $-15.42M | $193.33M | (m) | (m) | (m) | -7.97% |
| 2025-12-31 | $-7.67M | $194.06M | (m) | (m) | (m) | -3.95% |
| 2025-09-30 | $-5.29M | $246.48M | (m) | (m) | (m) | -2.15% |
| 2025-06-30 | $-2.03M | $245.56M | (m) | (m) | (m) | -0.83% |
| 2025-03-31 | $-7.43M | $234.01M | (m) | (m) | (m) | -3.18% |
| 2024-12-31 | $-16.14M | $212.45M | (m) | (m) | (m) | -7.60% |
| 2024-09-30 | $-19.33M | $193.06M | (m) | (m) | (m) | -10.01% |
| 2024-06-30 | $-19.22M | $178.28M | (m) | (m) | (m) | -10.78% |
| 2024-03-31 | $-17.81M | $163.56M | (m) | (m) | (m) | -10.89% |
| 2023-12-31 | $-14.49M | $152.55M | (m) | (m) | (m) | -9.50% |
| 2023-09-30 | $-22.69M | $135.81M | (m) | (m) | (m) | -16.71% |
| 2023-06-30 | $-25.18M | $128.61M | (m) | (m) | (m) | -19.58% |
| 2023-03-31 | $-33.19M | $123.12M | (m) | (m) | (m) | -26.96% |
| 2022-12-31 | $-43.45M | $119.03M | (m) | (m) | (m) | -36.50% |
| 2022-09-30 | $-49.23M | $118.33M | (m) | (m) | (m) | -41.60% |
| 2022-06-30 | $-55.00M | $111.87M | (m) | (m) | (m) | -49.17% |
| 2022-03-31 | $-55.49M | $103.72M | (m) | (m) | (m) | -53.50% |
| 2021-12-31 | $-54.30M | $92.88M | (m) | (m) | (m) | -58.47% |
| 2021-09-30 | $-72.96M | $78.35M | (m) | (m) | (m) | -93.12% |
| 2021-06-30 | $-80.91M | $64.41M | (m) | (m) | (m) | -125.61% |
| 2021-03-31 | $-68.00M | $51.19M | (m) | (m) | (m) | -132.84% |
| 2020-12-31 | $-57.82M | $37.29M | (m) | (m) | (m) | -155.04% |
| 2020-09-30 | $-26.01M | $15.96M | (m) | (m) | (m) | -162.98% |
| 2020-06-30 | $-6.45M | $8.08M | (m) | (m) | (m) | -79.84% |
| 2020-03-31 | $-4.07M | $1.69M | (m) | (m) | (m) | -240.72% |
| 2019-12-31 | $-2.89M | $83.55K | (m) | (m) | (m) | -3458.41% |
| 2019-09-30 | $-3.16M | $10.71M | (m) | (m) | (m) | -29.55% |
| 2019-06-30 | $-2.58M | $10.08M | (m) | (m) | (m) | -25.56% |
| 2019-03-31 | $-2.34M | $9.42M | (m) | (m) | (m) | -24.85% |
| 2018-12-31 | $-2.06M | $8.32M | (m) | (m) | (m) | -24.70% |
| 2018-09-30 | $-1.51M | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | $-1.34M | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | $-945.05K | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | $-1.07M | (m) | (m) | (m) | (m) | (m) |
| 2017-09-30 | $-1.58M | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | $-1.52M | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | $-1.44M | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | $-1.17M | (m) | (m) | (m) | (m) | (m) |
| 2016-09-30 | $-737.25K | $4.63M | (m) | (m) | (m) | -15.94% |
| 2016-06-30 | $-511.61K | $3.52M | (m) | (m) | (m) | -14.53% |
| 2016-03-31 | $-375.15K | $2.57M | (m) | (m) | (m) | -14.59% |
| 2015-12-31 | $-262.22K | $1.22M | (m) | $23.93K | (m) | -21.51% |
| 2015-09-30 | $-136.31K | $1.01M | (m) | (m) | (m) | -13.56% |
| 2015-06-30 | $-287.20K | $890.75K | (m) | (m) | (m) | -32.24% |
| 2015-03-31 | $-345.41K | $810.01K | (m) | (m) | (m) | -42.64% |
| 2014-12-31 | $-530.88K | $714.16K | (m) | (m) | (m) | -74.34% |
| 2014-09-30 | $-672.76K | $715.03K | (m) | (m) | (m) | -94.09% |
| 2014-06-30 | $-708.48K | $644.24K | (m) | (m) | (m) | -109.97% |
| 2014-03-31 | $-653.26K | $770.53K | (m) | (m) | (m) | -84.78% |
| 2013-12-31 | $-546.41K | $808.36K | (m) | (m) | (m) | -67.59% |
| 2013-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | $-540.02K | $673.78K | (m) | (m) | (m) | -80.15% |
| 2012-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| SBC Medical Group Holdings Inc (SBC) | United States | $0.487B | |
| Teladoc Health, Inc. (TDOC) | United States | $1.114B | -8.68 |